LANXESS has extended its portfolio by several novel alternatives, including formulations with the unique active ingredient
These DBDCB-based products are a good alternative for the MIT free and ZPT free preservation of in-can formulations in
order to prevent the H317 label on the end product.
The active ingredient DBDCB has a favorable profile:
- Long-term efficacy
- Broad spectrum efficacy including Pseudomonas and Fusarium species
- Good chemical compatibility with most formulation components
- Completely soluble in water-based products within dosage recommendation